Latest news with #AjayMahajan
Time of India
3 days ago
- Health
- Time of India
AI improving early detection, prevention in cardiac patients
Mumbai: Most Indian patients are unlikely to meet a cardiologist until they suffer chest pain, but artificial intelligence (AI)-based programmes could detect problems long before the symptoms. Tired of too many ads? go ad free now This is the reason why city hospitals are adopting AI in cardiac care. Two hospitals have upgraded their cardiac suite with an AI programme, while Jaslok Hospital on Pedder Road on Saturday said its cardiologists could, in outpatient settings, assess the cardiovascular risk of a patient in a few seconds. "Our main goal is prevention, not just treatment. Based on a cardiac profile, the AI programme will predict heart diseases in patients," said senior cardiologist Dr Ajit Desai from the hospital. Every third death in India is due to heart disease, underlining the urgency for preventive cardiac care. Experts told TOI that AI could play a role in detecting heart disease early enough for medicines to work. Dr Ajay Mahajan, head of cardiology at KEM Hospital, said, "AI can transform nearly every aspect of cardiac care—such as automatically flagging abnormal rhythms on ECGs or quantifying ventricular function and pinpointing valve lesions on an Echo scan. " He added that AI-guided optical coherence tomography (OCT) during angioplasty can measure vessel diameter, detect calcium, ensure optimal stent positioning and diagnose stent failures. Interventional cardiologist Dr Ananth Rao said, "With algorithms built into modern angiography suites, clinicians can now generate live 3D reconstructions of coronary vessels—pinpointing calcium deposits, soft plaques or clots—before they start the procedure." In short, he said, "AI is an absolute part of the future of medicine." tnn
Time of India
5 days ago
- Health
- Time of India
Cardiac medication sales shoot up 50% in five years
Mumbai: India's heart disease burden is evident not only from the spate of heart attacks among young celebrities in the past five years, but also in the over-50% rise in cardiac medication sale in the same period. Be they lipid-lowering drugs, heart-failure medications or anti-anginal treatments, cardiac medications sell more than drugs meant for any complications, including the gastro-intestinal tract, infections or diabetes. According to June report of Pharmarack, which analyses sales figures from 17 prominent Indian pharmaceutical companies representing more than half of the sector, sales of cardiac medicines rose from Rs 1,761 crore in June 2021 to Rs 2,645 crore by June 2025. There has been a consistent yearly growth rate of 10.7% in this sector, showed the report. Experts offer a slew of reasons for this rise, ranging from better awareness of heart diseases, new parameters for measuring hypertension as well as the increasing population of senior citizens. "There is no doubt that cardiovascular diseases are on the rise, but at the same time, access to care and diagnostic tools has improved," said Dr Ajay Mahajan, head of the cardiology department at KEM Hospital. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Nvidia's AI Strategy Is Clear - But Is Wall Street Paying Attention? Seeking Alpha Read More Undo Centre's data suggests that 63% of total deaths in the country were due to non-communicable diseases (NCDs), with cardiovascular diseases (CVDs) accounting for 27%. You Can Also Check: Mumbai AQI | Weather in Mumbai | Bank Holidays in Mumbai | Public Holidays in Mumbai Dr Suraj Nagre, associate professor at JJ Hospital's cardiovascular and thoracic surgery department, offers another reason: "A few years ago, the threshold for hypertension was a reading of 130-140. Medical guidelines have since changed and even readings above 120 are considered hypertensive." While heart care until a few years back mainly meant lipid-lowering medications, the prescriptions for other drugs meant to control unstable heart rhythm or heart failure have also increased. "Cardiovascular medications are interrelated because they target different but connected pathways of disease," said senior cardiac surgeon Dr Ramakanta Panda. "For example, anti-hypertensives lower blood pressure to reduce the strain on arteries and the heart. Lipid-lowering drugs like statins reduce cholesterol helping prevent arterial blockages. Anti-anginals improve blood flow to the heart muscle, relieving chest pain caused by narrowed arteries. These medications are often prescribed together," said Dr Panda. Referring to the frequent reports of cardiac arrest deaths among common people as well as celebrities and fitness enthusiasts, KEM cardiologist Dr Charan Lanjewar said underlying factors are almost always involved. "There's a lack of data to identify a single cause in many cardiac arrest cases. The reasons are multifactorial, but lifestyle, stress, and consumption habits play a vital role," he said. The aging population is more prone to heart conditions. Senior cardiologist Dr Akshay Mehta said, "The lifespan of the Indian population has increased and with a growing aging population, we are seeing a higher incidence of heart disease. Along with rising incidence, we also have better diagnostic tools now."
Hindustan Times
23-06-2025
- Business
- Hindustan Times
Western Command signs MoUs with IIT Ropar and IIT Kanpur to deepen defence-academia collaboration
Chandigarh, The Indian Army's Western Command has strengthened strategic collaborations with two premier institutions IIT Ropar and IIT Kanpur to foster joint research, innovation and indigenization for national defence applications. Western Command signs MoUs with IIT Ropar and IIT Kanpur to deepen defence-academia collaboration Earlier on February 25, the Technology Business Incubator Foundation as part of IIT Ropar's 16th Foundation Day hosted Lieutenant General Manoj Kumar Katiyar, General Officer Commanding-in-Chief, Western Command, and other senior officers at a startup and innovation showcase. The delegation, including Major General Ajay Mahajan, Major General Sunil Rampal, Brigadier Yogesh Kaura and Colonel Dinesh, was briefed on emerging defence-focused technologies by TBIF Director Dr Atharva Poundarik and IIT Ropar's Professor of Practice Lieutenant General Surinder Singh Mahal . The event featured ground-breaking innovations such as UAV systems, First-Person View drones using VR, drone forensics, electronic warfare solutions and tactical infrastructure technologies, said an official statement issued here on Monday. "The visit culminated in the signing of a landmark MoU between IIT Ropar and Western Command, establishing a structured framework for continued engagement in defence R&D and field-ready innovation," the statement said. Building on this momentum, IIT Kanpur on June 20 signed an MoU with the Western Command, reaffirming the Army's commitment to tapping into India's academic potential, it said. The MoU was signed by IIT Kanpur Director Prof Manindra Agrawal and Lieutenant General Katiyar in the presence of senior faculty and military leadership. The collaboration spans multiple disciplines, including engineering, physical sciences, biomedical sciences and cybersecurity. A detailed tour of IIT Kanpur's Startup Incubation and Innovation Centre and Centers of Excellence showcased innovations in smart systems, UAVs and real-time surveillance, led by startups like TerrAqua UAV Solutions, Maraal Aerospace and Xterra Robotics. The discussions with leading researchers, according to the statement, reflected a shared vision: accelerating indigenous defence technologies through sustained collaboration. These engagements signify a progressive roadmap for academic-military partnerships, blending intellectual capital with operational needs to address national security challenges. These coordinated efforts mark a new chapter in Army-academia synergy, transforming India's defence innovation ecosystem and reinforcing the Indian Army's commitment to nurturing indigenous, mission-ready technologies, it said. This article was generated from an automated news agency feed without modifications to text.
Yahoo
09-06-2025
- Business
- Yahoo
RTX's Collins Aerospace expands aircraft electrification capabilities in Europe
Company opens new engineering center of excellence in the UK and an aerostructures production line in France PARIS, June 9, 2025 /PRNewswire/ -- Collins Aerospace, an RTX (NYSE: RTX) business, expanded its aircraft electrification capabilities with the introduction of a new engineering center of excellence in Wolverhampton, UK, and a new electric thrust reverser actuation systems (elecTRAS™) production line in Colomiers, France. The Wolverhampton center focuses on developing next-generation electric thrust reverser actuation systems for commercial aircraft, featuring state-of-the-art design and test capabilities, and the Colomiers facility will handle the final assembly of these advanced electric systems, enhancing production efficiency and capacity. By switching from traditional hydraulic-powered thrust reverser actuation systems to elecTRAS, Collins can design nacelle systems that are easier for customers to install and maintain, while also reducing aircraft system weight by 15-20%. This improves fuel efficiency and operational performance. Collins currently supplies the elecTRAS on the Airbus A350 family. As part of an aircraft's nacelle system, thrust reversers redirect thrust from the plane's engines to help it slow down upon landing. The final assembly of the system in Colomiers will increase Collins' nacelle integration capacity and enhance customer proximity. Collectively, these efforts will strengthen Collins' aircraft electrification capabilities to support its global customer base. "With decades of experience in nacelles, thrust reversers, and aircraft electrification, Collins' elecTRAS center of excellence and production line will bring together expertise from across the company to deliver new, innovative solutions for our customers and future platforms," said Ajay Mahajan, president of Aerostructures at Collins Aerospace. "Building on in-service learning and experience, our dedicated investment to enable aircraft electrification technologies for the next-generation nacelle and elecTRAS will make future aircraft easier to maintain and operationally efficient." The new Wolverhampton site will serve as the engineering design center for elecTRAS, collaborating closely with Collins' Aerostructures headquarters in Chula Vista, California and other global engineering centers. It will also collaborate with Collins' electronic controls and motor systems center of excellence in Solihull, UK. With more than 600 A350XWB aircraft in service at the end of 2024 and continued production into the next decade, Collins' latest generation elecTRAS has accrued approximately 11 million flight hours and 1.8 million flight cycles of in-service operational experience. About Collins AerospaceCollins Aerospace, an RTX business, is a leader in integrated and intelligent solutions for the global aerospace and defense industry. Our 80,000 employees are dedicated to delivering future-focused technologies to advance sustainable and connected aviation, passenger safety and comfort, mission success, space exploration, and more About RTXRTX is the world's largest aerospace and defense company. With more than 185,000 global employees, we push the limits of technology and science to redefine how we connect and protect our world. Through industry-leading businesses – Collins Aerospace, Pratt & Whitney, and Raytheon – we are advancing aviation, engineering integrated defense systems for operational success, and developing next-generation technology solutions and manufacturing to help global customers address their most critical challenges. The company, with 2024 sales of more than $80 billion, is headquartered in Arlington, Virginia. For questions or to schedule an interview, please contact corporatepr@ View original content: SOURCE RTX
The Hindu
06-06-2025
- Health
- The Hindu
Haryana IMA seeks clarity on State govt.'s cashless treatment scheme for accident victims
In the wake of the Haryana Health Department's order to onboard all hospitals for a cashless road accident victims treatment scheme, the State chapter of the Indian Medical Association (IMA) has sought clarity on its various aspects, including the rates prescribed for the treatment. The scheme, launched in Haryana earlier this year as a pilot project along with five other States, had failed to take off after the private hospitals backed out of it citing several reasons, including the meagre treatment rates. In a letter to the Director General Health Services (DGHS) seeking clarification on the various aspects of the scheme, the Haryana IMA has sought details about the rates prescribed for the services such as consultation, ICU charges, room rent; the mode of payment; procedure for the empanelment of non-Ayushman Hospitals and access to the portal for the registration of these cases. The DGHS has directed all civil surgeons to onboard all hospitals for the scheme, especially those not empanelled under the Ayushman Bharat. Under the scheme, notified by Ministry of Road Transport and Highways in 2025, the road accident victims would be administered cashless emergency care of up to ₹1.5 lakh with a cap of maximum of seven days. The scheme is applicable across all categories of roads including National and State Highways and municipal roads. Former IMA chief Ajay Mahajan told The Hindu over phone that the government had earlier offered very low rates, only ₹1,000 per day including ICU charges, surgery, medicines and the investigations expenses. 'It is a good scheme and could help save road accident victims offering timely treatment. But the rates offered earlier were not practical. Many Ayushaman empanelled hospitals came forward, but had to back out due to very low rates and delayed payments. The road accident victims suffer multiple injuries and might require a lot of investigations such as frequent MRI. So, this scheme failed to take off in Haryana and now DGHS has asked civil surgeons to enrol other hospitals too. But there is no clarity on how the hospitals would be paid. This is bound to fail again,' said Dr. Mahajan. 'Meagre payment' In March too, the IMA had written to the DGHS after the launch of the scheme expressing concerns over low rates and lack of clarity on various issues. 'Unfortunately, at present the pilot project is being launched in Haryana without proper preparations. There are no proper guidelines on how the payments will be made, no separate MoU has been done and few cases that have been claimed are being paid a measly sum of ₹1,000 per day for general ward for a head injury case in Intensive Care Unit,' the letter had read. DGHS Manish Bansal did not respond to calls and text messages to seek his response.
